International Endeavors
Announces Agreement with Kubby Cryogenics, Inc. for Medical
Marijuana Expansion
TEMECULA, CA -- Oct. 13, 2017 -- InvestorsHub NewWire
-- International Endeavors Corporation (PINK:IDVV)
("IEC") is pleased to announce the Company has signed an MOU with
Kubby Cryogenics Inc.
Under the terms of this agreement:
Steve Kubby will immediately become CEO of International
Endeavor Corporation.
Kubby Cryogenics will look to patent medical grade cannabis
strains that are genetically profiled to treating specific
diseases.
The company will be acquiring licensing rights to patent new
delivery systems in the future. Further, the company will continue
with product development in their own proprietary Cryogenics line,
which captures the highest medical value of any product known on
the market today.
To accomplish these goals, Kubby Cryogenics has assembled a team
of top Scientists and Geneticists to research and develop the
strains for these Cryogenic Extract products.
Steve Kubby, commented, "We are very excited to partner with IEC,
and anticipate bringing a new class of medicine to the market
through our pure line of medical grade cannabis products featuring
our patent pending Cryogenic process. We will create a dispensary
system for legal medical cannabis states standardizing the patient
centered, consultation approach while presenting an enticing line
of Adult Use products featuring a patent pending menu of powerful
strains and pure, all natural, solvent-less concentrate
products."
Cryogenics Medical Uses
Cancer, Fibromyalgia, Arthritis, High Blood Pressure, Epilepsy,
Brain Injury, Stroke, Inflammation, and PTSD.
Mr. Steve Kubby Bio
Steven Wynn "Steve" Kubby played a key role in the passage of
California Proposition 215, a ballot initiative passed in 1996 to
legalize medical marijuana. He is a well-known cancer patient of 36
years, who benefits his recovery through the use of
non-psychoactive Cryogenics, a raw cannabis extract. Steve Kubby
was formally Chairman and CEO of Cannabis Sativa Inc., traded under
the symbol CBDS, and has authored 2 books on drug policy reform.
Mr. Kubby's distinguished political career includes runs for
Governor of California in 1998, and the 2008 Presidential primary
race under the libertarian ticket.
About International Endeavors Corporation
International Endeavors Corporation is a company focused on
biomedical uses of non-psychoactive cannabis based products for the
treatment of a wide variety of illnesses. Through a unique patent
pending Cryogenic process, the Company can process different unique
medical grade cannabis strains that are genetically profiled to
treating specific diseases. www.internationalendeavorscorp.com
Forward-Looking Statements are included within the meaning of
Section 27A of the Securities Act of 1933, and Section 21E of the
Securities Exchange Act of 1934, as amended. All statements
regarding our expected future financial position, results of
operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities,
plans and objectives of management for future operations, including
words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other
similar expressions are forward-looking statements and involve
risks, uncertainties and contingencies, many of which are beyond
our control, which may cause actual results, performance, or
achievements to differ materially from anticipated results,
performance, or achievements. International Endeavors Corporation
(IDVV)
is under no obligation to (and expressly disclaim any such
obligation to) update or alter our forward-looking statements,
whether as a result of new information, future events or
otherwise.
Contact:
Nobia Kubby
Chief Operations Officer
Phone: 831-383-2141
Email: Nobia@kubbyinc.com